Paul Miller, MD
Nephrology · Golden, CONPI 1174663819
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (54.1%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Radius Health, Inc. at 39.7% of the total. Reporting peaked in 2023 at $25,677 and has fallen 97.6% since, to $607 in 2025. Among nephrology clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 274 payments — averaging $153.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Radius Health, Inc.$17K
- Amgen$14K
- Kyowa Kirin, Inc.$9K
- AstraZeneca$812
- TG Therapeutics, Inc.$704
- KARL Storz Endoscopy-america$98
- plus $143 from 3 others
Across 81 payments — averaging $2149.64 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ultragenyx Pharmaceutical Inc.$66K
- Radius Health, Inc.$55K
- Amgen$34K
- EMD Serono, Inc.$9K
- AstraZeneca$5K
- Regeneron$5K
- plus $725 from 1 others
What the payments were for
- Consulting fees$7,01017%
- Speaking & faculty fees$22,80054%
- Travel & lodging$5,35913%
- Food & beverage$6,91616%
- Education$880%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Radius Health, Inc. | 193 | $16,735 |
| Amgen | 33 | $14,216 |
| Kyowa Kirin, Inc. | 11 | $9,466 |
| AstraZeneca | 22 | $812 |
| TG Therapeutics, Inc. | 6 | $704 |
| KARL Storz Endoscopy-america | 1 | $98 |
| Ultragenyx Pharmaceutical Inc. | 5 | $85 |
| Corcept Therapeutics | 2 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$42,174 in reported general payments places this provider in the 95th percentile of 152 nephrology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TymlosAbaloparatide | 315 | $879,533 |
| ForteoTeriparatide | 55 | $271,991 |
| Risedronate Sodium | 30 | $1,566 |
| Vitamin D2Ergocalciferol (Vitamin D2) | 11 | $201 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Radius Health, Inc.Tymlos | $16,735 | $879,533315 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 152 nephrology providers in Colorado.
Other nephrology in Golden
- Geoffrey BlockLone Tree$726K
- Laura KooiengaDenver$82K
- Brad MarderDenver$77K
- Richard JohnsonAurora$62K
- Maria VelezDenver$47K
- Bruce KaplanAurora$42K
- Michael ShomakerThornton$41K
- Sixto GiustiAurora$23K
- Joseph AbdallahWestminster$23K
- Isaac TeitelbaumAurora$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.